Odonate Therapeutics, Inc. (ODT) News
Filter ODT News Items
ODT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ODT News Highlights
- ODT's 30 day story count now stands at 3.
- Over the past 16 days, the trend for ODT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about ODT are LAW.
Latest ODT News From Around the Web
Below are the latest news stories about Odonate Therapeutics Inc that investors may wish to consider to help them evaluate ODT as an investment opportunity.
Odonate Announces Expected Delisting of Its StockNEW YORK, January 07, 2022--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC ("Nasdaq") notifying Odonate that Nasdaq believes that Odonate is a "public shell" pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted. Odonate will not appeal this determination. Therefore, Odonate expects the trading of its common stock on The Nasdaq Stock Market to be suspende |
SHAREHOLDER ALERT: Morris Kandinov Investigating CORT, MTCH, LDI, and ODT; Shareholders are Encouraged to Contact the FirmSAN DIEGO, Dec. 22, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Corcept Therapeutics, Inc., Match Group, Inc., Inc., loanDepot, Inc., and Odonate Therapeutics, Inc. If you are a current owner of shares of any of these stocks, contact [email protected] or call (619) 780-3993. |
Odonate Therapeutics, Inc. (NASDAQ:ODT) Sees Large Increase in Short InterestOdonate Therapeutics, Inc. (NASDAQ:ODT) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 513,400 shares, a growth of 85.0% from the November 15th total of 277,500 shares. Based on an average trading volume of 604,900 shares, the short-interest ratio is currently 0.8 days. [] |
Insider Buying: Odonate Therapeutics, Inc. (NASDAQ:ODT) Major Shareholder Acquires $308,662.06 in StockOdonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Ecor1 Capital, Llc purchased 185,941 shares of the companys stock in a transaction dated Wednesday, December 1st. The stock was purchased at an average price of $1.66 per share, for a total transaction of $308,662.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, [] |
Odonate Therapeutics, Inc. (NASDAQ:ODT) Shares Acquired by Assenagon Asset Management S.A.Assenagon Asset Management S.A. raised its holdings in shares of Odonate Therapeutics, Inc. (NASDAQ:ODT) by 543.1% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 346,296 shares of the companys stock after acquiring an additional 292,452 shares during the quarter. Assenagon Asset Management [] |
ODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics, Inc. - ODTFormer Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Odonate Therapeutics, Inc. (NasdaqGS: ODT). |
Ecor1 Capital, Llc Acquires 185,941 Shares of Odonate Therapeutics, Inc. (NASDAQ:ODT) StockOdonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Ecor1 Capital, Llc bought 185,941 shares of Odonate Therapeutics stock in a transaction that occurred on Wednesday, December 1st. The stock was bought at an average price of $1.66 per share, for a total transaction of $308,662.06. The purchase was disclosed in a legal filing with the Securities & [] |
State Street Corp Has $437,000 Stock Holdings in Odonate Therapeutics, Inc. (NASDAQ:ODT)State Street Corp cut its position in Odonate Therapeutics, Inc. (NASDAQ:ODT) by 67.2% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 125,138 shares of the companys stock after selling 255,980 shares during the quarter. State Street Corps holdings in Odonate Therapeutics were worth $437,000 as of its most recent SEC filing. Several other [] |
Marshall Wace North America L.P. Makes New Investment in Odonate Therapeutics, Inc. (NASDAQ:ODT)Marshall Wace North America L.P. acquired a new position in shares of Odonate Therapeutics, Inc. (NASDAQ:ODT) in the 2nd quarter, Holdings Channel.com reports. The fund acquired 39,890 shares of the companys stock, valued at approximately $139,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Susquehanna Fundamental Investments LLC purchased [] |
Odonate Therapeutics, Inc. (NASDAQ:ODT) Major Shareholder Sells $314,000.00 in StockOdonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Boxer Capital, Llc sold 200,000 shares of the companys stock in a transaction on Wednesday, November 24th. The stock was sold at an average price of $1.57, for a total transaction of $314,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible [] |